Our data reveal preexisting epithelial barrier damage in AD patients in suprabasal KCs, which is mainly driven by downregulation of cell–cell adhesion genes and confirms previously published data for chronic type 2-driven inflammation (Akdis, 2021). Here, TBCE is linked to Alzheimer disease.